Arrowhead Pharma doses first subjects in phase 1/2a study of ARO-MAPT to treat Alzheimer’s disease and other tauopathies: Pasadena, California Thursday, December 11, 2025, 12:00 ...
Polpharma Biologics and Libbs Farmacêutica ink licensing agreement for biosimilar for autoimmune diseases in Brazilian market: Switzerland Thursday, December 11, 2025, 11:00 Hrs ...
WHO & European Commission’s HERA sign €3.5 mn agreement to expand partnership to combat antimicrobial resistance under EU4Health programme: Geneva Thursday, December 11, 2025, ...
In a major enforcement drive, the Drugs Control Administration (DCA) in Himachal Pradesh, in coordination with the police department, conducted surprise raids at 20 drug manufacturing sites across the ...
US FDA grants Orphan Drug Designation to GSK’227, a B7-H3-targeted antibody-drug conjugate to treat small-cell lung cancer: London, UK Thursday, December 11, 2025, 09:00 Hrs [IS ...
Only 192 applications approved under RPTUAS to upgrade existing units to revised Schedule M standards: Gireesh Babu, New Delhi Thursday, December 11, 2025, 08:00 Hrs [IST] Even as ...
The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has sought pharma industry inputs to usher in industry engagement towards strengthening India-United Kingdom (UK) Comprehensive ...
Indian govt initiates discussion to fast-track approval for pharmaceuticals in Taiwan: Shardul Nautiyal, Mumbai Thursday, December 11, 2025, 08:00 Hrs [IST] The Government of Indi ...
RGUHS fee hike for pharmacy, medical & nursing education undermines State’s health education ecosystem: Nandita Vijayasimha, Bengaluru Thursday, December 11, 2025, 08:00 Hrs [IS ...
AICDF pushes for prosecution of pharma houses for decade-long non-compliance: Peethaambaran Kunnathoor, Chennai Thursday, December 11, 2025, 08:00 Hrs [IST] The All India Chemists ...
Roche’s Columvi combination shows sustained survival benefit at three-year follow up of pivotal phase III STARGLO study: Basel Wednesday, December 10, 2025, 18:00 Hrs [IST] Roch ...
Abbott announces Lingo, an OTC continuous glucose monitor and app, now available on Android devices: Abbott Park, Illinois Wednesday, December 10, 2025, 17:00 Hrs [IST] Abbott ann ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results